1.安徽医科大学第一附属医院 肿瘤内科，安徽 合肥 230022;2.哈佛大学医学院附属麻省总医院 Edwin. L. Steele肿瘤生物学实验室/放射肿瘤科，美国 波士顿 02114;3.中山大学附属第一医院 肝胆胰外科中心，广东 广州 510080;4.山东省肿瘤医院/山东第一医科大学附属肿瘤医院 消化肿瘤科，山东 济南 250117;5.浙江省人民医院/杭州医学院附属人民医院 肝胆胰外科及微创外科，浙江 杭州 310014;6.浙江大学医学院附属邵逸夫医院 普外科，浙江 杭州 310009;7.休斯敦卫理公会学术研究所 移植肿瘤学与治疗学中心/外科学系，美国 休斯敦 77030
1.Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China;2.Edwin. L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA;3.Center of Hepato-Pancreato-Biliary Surgery, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China;4.Department of Gastroenterology Oncology, Shandong Cancer Hospital and Institute/Shandong First Medical University and Shandong Academy of Medical Sciences, Ji'nan 250117, China;5.Department of Hepatobiliary Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital/Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, China;6.Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou 310009, China;7.Transplant Oncology and Therapeutics Program, Department of Surgery, Houston Methodist Academic Institute, Houston, TX 77030 USA
李敏,刘信,袁丹丹,王建国,陈江,Dan Gabriel DUDA.肝细胞癌的免疫治疗进展[J].中国普通外科杂志,2025,34(8):1618-1632.
DOI:10.7659/j. issn.1005-6947.250478